Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 11, 2014Journal of Pediatric Gastroenterology and Nutrition

Intestinal Expression of the Anti‐Inflammatory Interleukin‐1 Homologue IL‐37 in Pediatric Inflammatory Bowel Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SWSimon WeidlichTumkur UniversityABAna‐Maria BulauLudwig-Maximilians-Universität MünchenTSTobias SchwerdLMU Klinikum

Discussion

Loading...

Member takes

Implication

Observational study reveals epithelial and lymphoid IL-37 expression correlates with inflammation severity in pediatric IBD, suggesting a regulatory role in chronic gut inflammation.

Key Points

  • To assess the intestinal expression, cellular localization, and cytokine correlations of the anti-inflammatory cytokine IL-37 in children with chronic inflammatory bowel disease.
  • Obtained endoscopic intestinal biopsies from pediatric participants, comprising 18 patients with Crohn disease, 14 with ulcerative colitis, and 11 healthy controls.
  • Evaluated IL-37 protein and mRNA expression via immunohistochemistry and real-time polymerase chain reaction, correlating findings with histological inflammation severity, clinical parameters, and levels of IL-18, IL-17, IL-8, and IL-10.
  • IL-37 protein localized to intestinal epithelial cells and submucosal lymphoid cells in healthy controls and IBD patients, with higher lymphoid expression positively correlating with histological inflammation severity scores.
  • Messenger RNA levels of IL-8, IL-17, and IL-10 were significantly elevated in Crohn disease and ulcerative colitis, whereas IL-37 and IL-18 mRNA levels were not significantly elevated compared to controls but showed a positive correlation with each other in Crohn disease.

Cite This Study

Weidlich et al. (2014) studied this question.

synapsesocial.com/papers/6a9864e604c78a31a48c1406https://doi.org/10.1097/mpg.0000000000000387
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pediatric modification of the Montreal classification for inflammatory bowel disease2010 · 1,523 citations
  2. 2IL-37: a new anti-inflammatory cytokine of the IL-1 family2011 · 361 citations
  3. 3Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor2009 · 1,474 citations
  4. 4Proteomics‐based identification of proteins interacting with Smad3: SREBP‐2 forms a complex with Smad3 and inhibits its transcriptional activity2004 · 77 citations